Hijery ny anatiny

Oncologie (pédiatrie)

Gestion de la thrombocytopénie

Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (manokatra rohy)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Loharanon-kevitra‎: Pediatr Transplant 2017;21(6):e13017.

Rakitra‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (manokatra rohy)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (manokatra rohy)

Fassel H, Bussel JB, Roberts SS, Modak S

Loharanon-kevitra‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

Rakitra‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (manokatra rohy)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (manokatra rohy)

Jacobson AE, Shah N, Setty BA

Loharanon-kevitra‎: Pediatr Blood Cancer 2017;64(8):e26473.

Rakitra‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (manokatra rohy)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (manokatra rohy)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Loharanon-kevitra‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

Rakitra‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (manokatra rohy)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (manokatra rohy)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Loharanon-kevitra‎: Int J Hematol 2015;102(5):626-32.

Rakitra‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (manokatra rohy)

Chemotherapy induced thrombocytopenia in pediatric oncology. (manokatra rohy)

Tamamyan G, Danielyan S, Lambert MP

Loharanon-kevitra‎: Crit Rev Oncol Hematol 2016;99:299-307.

Rakitra‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (manokatra rohy)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (manokatra rohy)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Loharanon-kevitra‎: Onkologie 2004;27(2):131-7.

Rakitra‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (manokatra rohy)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (manokatra rohy)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Loharanon-kevitra‎: Ann Oncol 2005;16(1):139-45.

Rakitra‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (manokatra rohy)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (manokatra rohy)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Loharanon-kevitra‎: Blood 1998;91(10):3601-6.

Rakitra‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (manokatra rohy)